These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5899548)

  • 41. [Leprosy in Guadeloupe].
    Floch HA
    Bull Soc Pathol Exot Filiales; 1972; 65(1):35-46. PubMed ID: 4677872
    [No Abstract]   [Full Text] [Related]  

  • 42. [Re-evaluation of anti-Hansenian chemotherapy by long-term study and by experimental and pharmacokinetic criteria].
    Carayon A
    Acta Leprol; 1980; (79):55-65. PubMed ID: 6794334
    [No Abstract]   [Full Text] [Related]  

  • 43. [Leprosy, a neurologic disease].
    Coeytaux A; Truffert A; Mueller Y; Antille C; Jackson Y
    Rev Med Suisse; 2007 May; 3(110):1178, 1180-4. PubMed ID: 17564345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Rapid action of isoniazid in a case of reactional leprosy].
    Laugier P; Ellena V; Barale T
    Bull Soc Fr Dermatol Syphiligr; 1966 Dec; 73(6):899-900. PubMed ID: 5987869
    [No Abstract]   [Full Text] [Related]  

  • 46. [Rapidly resolutive action of thalidomide on recurrences of leprosy].
    Degos R; Lortat-Jacob E; Civatte J; Daniel F
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(5):474-8. PubMed ID: 5987422
    [No Abstract]   [Full Text] [Related]  

  • 47. Failure to induce delayed-type hypersensitivity to Mycobacterium leprae in long-term treated lepromatous leprosy patients.
    Smelt AH; Rees RH; Liew FY
    Clin Exp Immunol; 1981 Jun; 44(3):507-11. PubMed ID: 7035031
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Lessening of the action of sulfamethoxypyridine: cutaneous outbreak of previously cleared up lepromatous leprosy].
    Merklen FP; Cottenot F; Moulias R
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(5):473. PubMed ID: 5987421
    [No Abstract]   [Full Text] [Related]  

  • 49. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol Chemother; 1969; 7():211-51. PubMed ID: 4910168
    [No Abstract]   [Full Text] [Related]  

  • 50. [Considerations on plans for dosage of delayed-action sulfamides].
    Plancher AC; Salvi G; Strata A; Valdrè MV
    Clin Ter; 1967 Feb; 40(4):334-9. PubMed ID: 6077853
    [No Abstract]   [Full Text] [Related]  

  • 51. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage.
    Naafs B
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120
    [No Abstract]   [Full Text] [Related]  

  • 52. [Indications for delayed-action sulfonamide therapy. Adverse effects and complications of sulfonamide therapy].
    Leng-Lévy J; Aubertin J; Leng B; Magendie P; Marion J
    J Med Bord; 1967 Oct; 144(10):1465-88. PubMed ID: 5605725
    [No Abstract]   [Full Text] [Related]  

  • 53. Leprosy treatment and control of leprosy in India. (Assessment of achievements and suggestions for the future).
    Chatterjee SN
    Lepr India; 1980 Oct; 52(4):573-81. PubMed ID: 7193261
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of leprosy: science or politics?
    Naafs B
    Trop Med Int Health; 2006 Mar; 11(3):268-78. PubMed ID: 16553906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early diagnosis and treatment of leprosy in the United States.
    Style A
    Am Fam Physician; 1995 Jul; 52(1):172-8. PubMed ID: 7604761
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leprosy research at the National Institutes of Health: experience with B.663 in the treatment of leprosy.
    Williams TW; Mott PD; Wertlake PT; Rubio JB; Adler RC; Hill GJ; Suarez GP; Knight V
    Int J Lepr; 1965; 33(3):Suppl:767-77. PubMed ID: 5322715
    [No Abstract]   [Full Text] [Related]  

  • 57. [Current state of thalidomide treatment of leprosy and leprosy reaction].
    Sheskin J; Sagher F
    Arch Klin Exp Dermatol; 1970; 237(1):312-6. PubMed ID: 4906813
    [No Abstract]   [Full Text] [Related]  

  • 58. [Value of the combination of 4-aminoquinoline and sulfamethoxypyridazine in treatment of the tuberculoid form of Hansen's disease. Results obtained after 5 years of observation].
    Chum-Chantholl
    Bull Soc Pathol Exot Filiales; 1968; 61(4):504-10. PubMed ID: 5756653
    [No Abstract]   [Full Text] [Related]  

  • 59. Etiological factors in delayed-type hypersensitivity reactions in leprosy.
    Klenerman P
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):702-12. PubMed ID: 3123582
    [No Abstract]   [Full Text] [Related]  

  • 60. Chemotherapeutic trials in leprosy. 2. Comparative trial of dapsone plus ditophal (Etisul) and dapsone alone in the treatment of lepromatous leprosy.
    Waters MF; Pettit JH
    Int J Lepr; 1965; 33(3):280-96. PubMed ID: 5322767
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.